Citation Impact
Citing Papers
Serum Albumin
1985 Standout
Risk of colorectal cancer and other cancers in patients with gall stones.
1996
Peanuts as functional food: a review
2015 Standout
Enzymatic measurement of choline-containing phospholipids in bile.
1981
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
2011 Standout
Quantitative aspects of the interaction of bile acids with human serum albumin.
1982
Risk Assessment in Cholelithiasis: Is Cholecystectomy Always to be Preferred?
2010
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Close Relation Between Cirrhosis and Gallstones
1999
Effect of Simvastatin, Ursodeoxycholic Acid and Simvastatin Plus Ursodeoxycholic Acid on Biliary Lipid Secretion and Cholic Acid Kinetics in Nonfamilial Hypercholesterolemia
1992
Hepatocellular carcinoma
2003 Standout
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy
2001
Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
2010
Nonalcoholic fatty liver disease and aging: Epidemiology to management
2014
Gallstones, cholecystectomy and irritable bowel syndrome (IBS)
2008
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
2002 Standout
Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century?
2005
Functional Gastroduodenal Disorders
2006 Standout
Hepatic insulin resistance directly promotes formation of cholesterol gallstones
2008
Gallstone disease in non‐alcoholic fatty liver: Prevalence and associated factors
2005
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Glycemic Load, Glycemic Index, and Carbohydrate Intake in Relation to Risk of Cholecystectomy in Women
2005
Clinical manifestations of gallstone disease: Evidence from the multicenter Italian study on cholelithiasis (MICOL)
1999
Epidemiology of gallbladder stone disease
2006
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation
1994
Effect of thiazide treatment on biliary lipid composition in healthy volunteers
1989
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Influence of Laparoscopic Cholecystectomy on the Prevalence of Operations for Gallstones in Norway
2002
Structure of Serum Albumin
1994 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
2014 Standout
Epidemiology of gallstone disease in Chandigarh: A community‐based study
2001
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC)
1998
Deoxycholic acid and the pathogenesis of gall stones.
1988
Influence of Pravastatin, a Specific Inhibitor of HMG-CoA Reductase, on Hepatic Metabolism of Cholesterol
1990
Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey
2006
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Clinical and economic burden of postoperative pulmonary complications: Patient safety summit on definition, risk-reducing interventions, and preventive strategies*
2011
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Bile salt biotransformations by human intestinal bacteria
2005 Standout
Familial Aggregation of Insulin Resistance in First-Degree Relatives of Patients With Nonalcoholic Fatty Liver Disease
2006
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
2001
Gallbladder bile composition in patients with Crohn’s disease
2006
Liver transplantation and hepatitis C
2011
Screening for hepatocellular carcinoma in cirrhosis
2003
Endocrine and liver interaction: the role of endocrine pathways in NASH
2009
A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery
2013 Standout
Pharmacokinetics in the newborn
2003
Diet and gallstones in italy: The cross-sectional MICOL results†
1998
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Hepatitis C therapy before and after liver transplantation
2008
The repeatability of behaviour: a meta-analysis
2009 Standout
Gallstones and the risk of biliary tract cancer: a population-based study in China
2007
Hyperinsulinemia, Dyslipidemia, and Obesity as Risk Factors for Hospitalized Gallbladder Disease
2002
A Prospective Study of Coffee Consumption and the Risk of Symptomatic Gallstone Disease in Men
1999
Frequent nut consumption and decreased risk of cholecystectomy in women
2004
The gut microbiota — masters of host development and physiology
2013 Standout
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone‐free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones
2000
Natural history of inoperable hepatocellular carcinoma: Estrogen receptors’ status in the tumor is the strongest prognostic factor for survival
2000
Gallbladder cancer: epidemiology and outcome
2014 Standout
Effect of Chronic Administration of Tauro-hyodeoxycholic Acid on Biliary Bile Acid Composition and on Biliary Lipid Secretion in Humans
2001
Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
2006
Insulin Resistance Causes Human Gallbladder Dysmotility
2006
High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation
2003
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Independent Risk Factors for Gallstone Formation in a Region with High Cholelithiasis Prevalence
2005
Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses
2002 Standout
Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study
2010
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
2017
Should Cholecystectomy Be Performed for Asymptomatic Cholelithiasis in Transplant Patients?
2003
Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men
2005
Lithogenesis and Bile Metabolism
2008
Prevalence of gallstones in sonographic surveys worldwide
1999
Prospective study of abdominal adiposity and gallstone disease in US men
2004
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
2012 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
2010 Standout
Health Benefits of Nut Consumption
2010 Standout
Biology ofGiardia lamblia
2001 Standout
Abdominal Symptoms: Do They Predict Gallstones?: A Systematic Review
2000
Fitness consequences of personality: a meta-analysis
2008
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study
2013
Prevalence of Gallbladder Stone Disease in Obese Children and Adolescents: Influence of the Degree of Obesity, Sex, and Pubertal Development
2005
Asymptomatic Cholelithiasis: Is Cholecystectomy Really Needed? A Critical Reappraisal 15 Years After the Introduction of Laparoscopic Cholecystectomy
2007
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review
2011
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
COLONIC BACTERIAL ACTIVITY, BILIARY CHOLESTEROL SATURATION, AND PATHOGENESIS OF GALLSTONES
1978
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Secretion, Composition and Flow of Bile
1983
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
2007 Standout
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
2017
Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews
2010
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cholesterol oxidases: Properties and applications
1976
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Major Hepatic Resection A 25-Year Experience
1983
The role of bile acids in colonic carcinogenesis
1985
Influence of Age on Secretion of Cholesterol and Synthesis of Bile Acids by the Liver
1985
Liver transplantation for hepatocellular carcinoma
1995
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Biliary lipids support serum-free growth of Giardia lamblia
1986
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Resection of colorectal liver metastases
1995 Standout
Works of C Sama being referenced
Caroli's disease. description of a rare clinical case with monolobar localization.
1979
Enterohepatic circulation of bile acids after cholecystectomy.
1978
Factors associated with gallstone disease in the MICOL experience
1997
Small (≤3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT
2009
Coagulation and Fibrinolysis in Orthotopic Liver Transplantation: Role of the Recipient’s Disease and Use of Antithrombin III Concentrates
1991
Meta‐analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro‐oesophageal reflux disease
2007
Pulmonary complications of liver transplantation: radiological appearance and statistical evaluation of risk factors in 300 cases
2000
High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?: Table 1
2006
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
1990
Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum.
1977
Enzymatic determination of cholesterol in bile
1975
Gallstones and diabetes
1993
The Medical Treatment of Cholesterol Gallstones: Experience with Chenodeoxycholic Acid
1976
Epidemiology of Gallstone Disease in Italy: Prevalence Data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)
1995
A radioimmunoassay for lithocholic acid conjugates in human serum and liver tissue
1978
Serum Bile Acids in Newborns and Children
1980
Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or notherapy in preventing hepatitis B (HBV) recurrence after livertransplantation (LT)
2000
The role of liver transplantation in the treatment of hepatocellular carcinoma.
1992